Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models.
Clappaert EJ, Kancheva D, Brughmans J, Debraekeleer A, Bardet PMR, Elkrim Y, Lacroix D, Živalj M, Hamouda AEI, Van Ginderachter JA, Deschoemaeker S, Laoui D. Clappaert EJ, et al. Among authors: van ginderachter ja. Front Immunol. 2023 Aug 9;14:1166180. doi: 10.3389/fimmu.2023.1166180. eCollection 2023. Front Immunol. 2023. PMID: 37622122 Free PMC article.
Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.
Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Van den Bossche J, Mack M, Pipeleers D, In't Veld P, De Baetselier P, Van Ginderachter JA. Movahedi K, et al. Among authors: van den bossche j, van ginderachter ja. Cancer Res. 2010 Jul 15;70(14):5728-39. doi: 10.1158/0008-5472.CAN-09-4672. Epub 2010 Jun 22. Cancer Res. 2010. PMID: 20570887
Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site.
Laoui D, Van Overmeire E, Movahedi K, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Laoui D, et al. Among authors: van den bossche j, van ginderachter ja, van overmeire e. Immunobiology. 2011 Nov;216(11):1192-202. doi: 10.1016/j.imbio.2011.06.007. Epub 2011 Jun 30. Immunobiology. 2011. PMID: 21803441 Review.
Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.
Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA. Laoui D, et al. Among authors: van den bossche j, van ginderachter ja, van overmeire e. Int J Dev Biol. 2011;55(7-9):861-7. doi: 10.1387/ijdb.113371dl. Int J Dev Biol. 2011. PMID: 22161841 Free article. Review.
Claudin-1, claudin-2 and claudin-11 genes differentially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite- and tumour-elicited macrophages in vivo.
Van den Bossche J, Laoui D, Morias Y, Movahedi K, Raes G, De Baetselier P, Van Ginderachter JA. Van den Bossche J, et al. Among authors: van ginderachter ja. Scand J Immunol. 2012 Jun;75(6):588-98. doi: 10.1111/j.1365-3083.2012.02689.x. Scand J Immunol. 2012. PMID: 22268650 Free article.
Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K, Schoonooghe S, Laoui D, Houbracken I, Waelput W, Breckpot K, Bouwens L, Lahoutte T, De Baetselier P, Raes G, Devoogdt N, Van Ginderachter JA. Movahedi K, et al. Among authors: van ginderachter ja. Cancer Res. 2012 Aug 15;72(16):4165-77. doi: 10.1158/0008-5472.CAN-11-2994. Epub 2012 Jun 19. Cancer Res. 2012. PMID: 22719068
157 results